Advanced Filters
noise

Human Papilloma Virus Clinical Trials

A listing of Human Papilloma Virus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 280 clinical trials
K Katrien Van Tornout

Fertility Preservation in Young Women With Cancer

The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded. Study population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared …

- 40 years of age Female Phase N/A
M Miriam Wilhelm, Dr.

Fertility Protection for Children, Adolescents and Young Adults

This study focuses on improving fertility preservation and long-term care for children, adolescents, and young adults (CAYA) undergoing cancer treatments or stem cell transplantation. These treatments can harm fertility, and ensuring that patients receive the right support and follow-up care is critical. The main study goals are: Understanding Fertility Risks: …

years of age All Phase N/A
N Natan Bar-Chama, MD

Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)

This study will aim to assess the fertility status of men with Spinal Muscular Atrophy (SMA) not on disease-modifying therapies. Participants will: Complete online questionnaires that will assess SMA diagnosis and disease burden, medical and surgical history, medication usage, and fertility status and perspectives. Over the 3-month initial study baseline …

18 - 50 years of age Male Phase N/A

The Effect of Tucking on Semen Quality of Adult Trans Women

Because gender-affirming hormone therapy (GAHT) can lead to fertility impairment, current guidelines and treatment recommendations require that patients be informed about the possibility of fertility preservation prior to initiating GAHT. A recent review by our working group analyzed the current data on fertility and fertility preservation in transgender and gender …

18 - 50 years of age Male Phase N/A
M Meryem Guler

Overture Metabolomics Non-Selection Study

In this study, study investigators will collect embryo culture media on day 5 of vitro fertilization (IVF) culture, prior to vitrification and embryo transfer for testing via Metabolomic screening. Metabolomics is a new, non-invasive method of embryo selection which involves testing discarded embryo culture media for analytes secreted by the …

18 - 50 years of age Female Phase N/A

What To-be-discard Biomaterials From ART Cycles Can Tell us About the Treatment Cycle Outcome?

Various to-be-discard material from IVF treatment cycle will be collect and examined, aiming to identify potential reasons of successful outcome or cycle failure.

18 years of age All Phase N/A
R Rachel Makloski, RN

DNA Analysis of Discarded Media Drops From the Clinical IVF Cycles

Performing DNA analysis of discarded media drops from the clinical IVF cycles completed in our Center

18 - 44 years of age Female Phase N/A

Metabolomics Non Selection Study - Vitrolife Media

In this study, study investigators will collect embryo culture media on day 5 of vitro fertilization (IVF) culture, prior to vitrification and embryo transfer for testing via Metabolomic screening. Metabolomics is a new, non-invasive method of embryo selection which involves testing discarded embryo culture media for analytes secreted by the …

18 - 38 years of age Female Phase N/A
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

Background Medical advances have improved survival rates for many cancers and other illnesses. This means that more people are coping with the long-term effects of these treatments. Some treatments can cause female infertility. Ovarian tissue cryopreservation (OTC) may help. Before undergoing a treatment that may damage their fertility, patients may …

4 - 35 years of age Female Phase N/A
H Hadas Lemberg, PhD

Derivation of New Human Embryonic Stem Cell Lines Lines for Clinical Use

Human embryonic stem cells (hESCs) are isolated from the early human embryo and have the capability to proliferate indefinitely in culture and to develop into nearly every cell of the human body. Therefore, hESCs may serve as a renewable unlimited source of cells for transplantation therapy. Because of the use …

18 years of age All Phase N/A

Simplify language using AI